Capstone Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Capstone Asset Management's IDXX Position: Q2 2017 in Review
Capstone Asset Management reduced its Idexx Laboratories (IDXX) stake by 2.8% in Q2 2017, selling an estimated $81.2K and leaving 17,178 shares worth $2.77M. The position accounts for 0.08% of the portfolio, ranked #307.
Capstone Asset Management first reported a position in IDXX in Q2 2013 and has held it in 17 quarters since. 582 funds tracked by Wall St. Rank hold IDXX as of Q2 2017.
- Capstone Asset Management held 17,178 shares of Idexx Laboratories worth $2.77M as of Q2 2017.
- Capstone Asset Management sold 500 Idexx Laboratories shares in Q2 2017, an estimated $81.2K.
- Idexx Laboratories made up 0.08% of Capstone Asset Management's portfolio in Q2 2017, its #307 holding.
- Capstone Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 17 quarters since.
- 582 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.